AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 47 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $632,148 | -39.0% | 243,134 | 0.0% | 0.51% | -30.4% |
| Q1 2024 | $1,035,751 | +110.9% | 243,134 | 0.0% | 0.74% | +107.9% |
| Q4 2023 | $491,131 | +32.0% | 243,134 | 0.0% | 0.35% | +11.3% |
| Q3 2023 | $371,995 | -7.3% | 243,134 | 0.0% | 0.32% | -1.9% |
| Q2 2023 | $401,171 | +44.7% | 243,134 | 0.0% | 0.32% | +30.1% |
| Q1 2023 | $277,173 | +26.4% | 243,134 | 0.0% | 0.25% | +39.1% |
| Q4 2022 | $219,331 | -22.8% | 243,134 | 0.0% | 0.18% | -21.8% |
| Q3 2022 | $284,000 | +82.1% | 243,134 | 0.0% | 0.23% | +78.9% |
| Q2 2022 | $156,000 | -75.4% | 243,134 | 0.0% | 0.13% | -69.0% |
| Q1 2022 | $635,000 | -32.9% | 243,134 | 0.0% | 0.41% | -29.4% |
| Q4 2021 | $946,000 | -10.8% | 243,134 | 0.0% | 0.58% | -11.6% |
| Q3 2021 | $1,060,000 | +9.8% | 243,134 | 0.0% | 0.66% | +8.2% |
| Q2 2021 | $965,000 | – | 243,134 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $42,776,000 | 100.00% |
| Latash Investments, LLC | 243,134 | $1,060,000 | 0.66% |
| Bracebridge Capital, LLC | 428,571 | $1,869,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 297,229 | $1,296,000 | 0.13% |
| PDT Partners, LLC | 76,100 | $332,000 | 0.02% |
| Jump Financial, LLC | 49,700 | $216,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 183,000 | $798,000 | 0.02% |
| IndexIQ Advisors LLC | 86,461 | $377,000 | 0.01% |
| Financial Advocates Investment Management | 17,000 | $74,000 | 0.01% |
| Brandywine Global Investment Management, LLC | 125,016 | $545,000 | 0.00% |